Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

5.430 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 7, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	10,145
Open	5.430
Bid (Size)	5.280 (200)
Ask (Size)	5.450 (100)
Prev. Close	5.430
Today's Range	5.430 - 5.430
52wk Range	3.710 - 8.740
Shares Outstanding	14,508,063
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Securities Fraud Investigation Into Unicycive Therapeutics, Inc. (UNCY) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

July 07, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

UNCY SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

July 06, 2026

From Kirby McInerney LLP

Via GlobeNewswire

Performance

YTD	-6.4%	-6.4%
1 Month	-18.5%	-18.5%
3 Month	-18.7%	-18.7%
6 Month	-3.9%	-3.9%
1 Year	+15.8%	+15.8%

More News

Bragar Eagel & Squire, P.C. is Investigating Unicycive Therapeutics, Inc. on Behalf of Unicycive Stockholders and Encourages Investors to Contact the Firm

July 02, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

UNICYCIVE THERAPEUTICS, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

July 01, 2026

From Kirby McInerney LLP

Via Business Wire

Wondering what's happening in today's after-hours session? ↗

July 01, 2026

Via Chartmill

Here are the top movers in Tuesday's session. ↗

June 30, 2026

Via Chartmill

Top movers analysis in the middle of the day on 2026-06-30: top gainers and losers in today's session. ↗

June 30, 2026

Via Chartmill

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

June 30, 2026

Via Chartmill

Tuesday's pre-market session: top gainers and losers ↗

June 30, 2026

Via Chartmill

Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on

March 18, 2026

From Grabar Law Office

Via GlobeNewswire

Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

March 16, 2026

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Integer Holdings Corp. (NYSE: ITGR): Molina Healthcare, Inc. (NYSE: MOH); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on

March 12, 2026

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Boston Scientific Corporation (NYSE: BSX): Corcept Therapeutics, Inc. (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR): and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims

March 10, 2026

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Kyndryl Holdings (NYSE: KD); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your

March 05, 2026

From Grabar Law Office

Via GlobeNewswire

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

December 18, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Five Below, Inc. (NASDAQ: FIVE); Molina Healthcare, Inc. (NYSE: MOH); Synopsys, Inc. (NASDAQ: SNPS); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

December 03, 2025

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims

December 02, 2025

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Five Below, Inc. (NASDAQ: FIVE); Maison Solutions Inc. (NASDAQ: MSS); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

November 14, 2025

From Grabar Law Office

Via GlobeNewswire

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

November 13, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Five Below, Inc. (NASDAQ: FIVE); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

November 10, 2025

From Grabar Law Office

Via GlobeNewswire

UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. is Investigating Unicycive Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 31, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); Treace Medical Concepts (NASDAQ: TMCI); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

October 27, 2025

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of CS Disco Inc. (NYSE: LAW); Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

October 24, 2025

From Grabar Law Office

Via GlobeNewswire

UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

October 14, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics

October 13, 2025

From Faruqi & Faruqi, LLP

Via Business Wire

Frequently Asked Questions

Is Unicycive Therapeutics, Inc. - Common Stock publicly traded?

Yes, Unicycive Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Unicycive Therapeutics, Inc. - Common Stock trade on?

Unicycive Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Unicycive Therapeutics, Inc. - Common Stock?

The ticker symbol for Unicycive Therapeutics, Inc. - Common Stock is UNCY on the Nasdaq Stock Market

What is the current price of Unicycive Therapeutics, Inc. - Common Stock?

The current price of Unicycive Therapeutics, Inc. - Common Stock is 5.430

When was Unicycive Therapeutics, Inc. - Common Stock last traded?

The last trade of Unicycive Therapeutics, Inc. - Common Stock was at 07/07/26 04:00 PM ET

What is the market capitalization of Unicycive Therapeutics, Inc. - Common Stock?

The market capitalization of Unicycive Therapeutics, Inc. - Common Stock is 78.78M

How many shares of Unicycive Therapeutics, Inc. - Common Stock are outstanding?

Unicycive Therapeutics, Inc. - Common Stock has 79M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.